Tag: RUN

Blue Horseshoe Stocks: BBLU Update & More

Blue Earth, Inc. BBLU – Update

While we most commonly look for short-term, quick-strike trading opportunities, every so often we’ll sneak in a longer-term play, and that’s just what we did on Tuesday of last week with BBLU.

BBLU had just begun to undergo a massive selloff with no prompt from a filing or news release. This caused us to take notice and tag the stock for extended observation. Our exact words were “We’ll go ahead and reserve a slot on our radar screens for BBLU with an extended bottom-watch designation. It’s far better to show up to the party early and be ready to strike immediately upon the slightest hint of a rebound.”

As it turns out, we were absolutely spot-on in our assessment of BBLU and how to approach it. After ultimately bottoming out at a low of .04 at the end of last week, the recovery has been a thing of beauty. BBLU caught fire and ran back to a subsequent high of .23, regaining its lost ground just as we suspected. That’s an incredible 475% swing!

As we point out on the chart below, things are still looking ripe for yet another leg-up, so we’ll keep a keen eye on BBLU in the sessions ahead.

Added Notes:

Speaking of bottom-plays, we have a couple of other familiar stocks that are just now trading at their own recent lows, and could be in line for recoveries.

We’ve been tagging them in our extended watchlists recently, and we’re going to have them both on a more intensive watch moving forward.

Axion Power International, Inc. AXPW

Skyline Medical, Inc. SKLN

Fresh Options Idea

We’ll look to further our success with options plays this week with an idea we feel has good potential based on a favorable earnings report.

Dollar General, Inc. (DG) is gapping up this morning into the $79-range, so we’re going to be on the lookout for a possible dip-and-rip situation, whereupon we’ll be tracking DG Weekly $78-80.50 Calls for possible daytrade and/or swing trades into tomorrow’s session.

Extended Watchlist:
AVXL, ANTH, BOX, RUN, HGG, PGEI, DEAC, SCIE

Blue Horseshoe Stocks: SPY Review & More

SPDR S&P 500 ETF (SPY) – Options Recap

We continued to track our successful options idea from earlier in the week yesterday morning, as the SPY Weekly $188-191 Calls once again provided ammunition for some serious gains. Despite already having moved up considerably, we mentioned our expectations that those figures would be pushed higher and indeed they were.

As we did yesterday to save time, we’ll just outline the gains made by the bookend contracts of our observed range; similar gains would have been up for grabs in any of the contracts within. The $188 Calls extended their new high to 5.35, which represents a 226% overall move, and the $191’s  pushed to 2.68- a gain of 587% over Tuesday’s low.

In addition to tracking our initial idea, our trader’s chat participants* were offered a followup idea prior to the bell yesterday that yielded big-time profit chances as well. As you can see from the screen capture below, we mentioned the possibility of rolling strike prices up to the $189.50-193.50 range, and all of those contracts were winners as well.

To give an idea of the gains available in that range, the $189.50’s made a move from 2.14-3.99 (+86%), while at the upper end, the $193.50 Calls made a 326% rip from .23-.98. All in all, there was no way to go wrong with any of our SPY Calls as the overall markets solidified their first three-day rally of 2016.

*Participation in our daily trader’s chats which currently take place via Skype is fun, free, and as simple as sending a contact request to username ‘stocksumo‘. All of our loyal readers are encouraged to take part!

Catalyst Pharmaceuticals, Inc. CPRX

We’ve spotted what could turn out to be a solid rebound play in CPRX this morning. On the heels of the company’s announcement that the FDA had served it with a letter of refusal pertaining to a recent NDA filing, the stock absolutely tanked.

The caveat is, the notice came with assurance that it was not related to the clinical data or perceived efficacy of the drug in question, but a filing error only. This means that the stock lost a good portion of its value in a single day for what seems to amount to nothing more than a clerical error (see chart below). We’ll be very interested to monitor the stock in coming sessions and observe its reaction.

Extended Watchlist:
BRCD, GLUU, RUN, EPXY, ECPN, FILM, NUUU, NWPN,